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Background: S100P, a protein originally detected in the human placenta, has been found to play an important role
in the development and invasion of tumors. Interestingly, we have recently discovered using data mining that
S100P was considerably up-regulated during the window of implantation in the human endometrium, but little
further information has been available.
Methods: Real-time PCR and immunofluorescence were performed to examine the expression and location of
S100P in the human endometrium and endometrial cells. Estrogen and progesterone were added to the cultured
cells to test the response of S100P to sex steroids.
Results: A dramatic peak, approximately a 100-fold increase in comparison with the proliferative and early- and
late-secretory phases, was observed in the endometrium during the mid-secretory phase, which corresponds to the
time of embryo implantation. Progesterone regulated the expression of S100P in both primary endometrial
epithelial and stromal cells, but estrogen had no significant effect.
Conclusions: The results indicate that S100P participates in the periodic change of the endometrium under the
regulation of progesterone, may be used as a unique biomarker of the receptive endometrium and play an
important role in embryo implantation.
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Embryo implantation is a bottleneck that limits success-
ful pregnancy. A receptive endometrium and viable
blastocyst are the two necessary conditions of successful
implantation [1]. The endometrium is receptive only
during the window of implantation, which lasts approxi-
mately four days (day 20–23), and occurs in humans
during the mid-secretory phase in a normal 28-day men-
strual cycle [2]. During the window of implantation, the
endometrium undergoes extensive morphological and
physiological changes to facilitate implantation of the
embryo, including becoming more vascular and edema-
tous with the glands displaying enhanced secretory activ-
ity [3]. This process is precisely regulated. Among all the* Correspondence: zhang.wei.fudan@gmail.com
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reproduction in any medium, provided the orregulating elements, reproductive hormones are the
leading factors.
Recently, investigators have made great efforts to elu-
cidate the molecular mechanisms of endometrial recep-
tivity, and they have pursued biomarkers to identify the
receptive endometrium. Previously, we employed bio-
informatics to mine the existing microarrays and
acquired a group of potential biomarkers [4], among
them S100P attracted our attention.
S100P, originally isolated from the placenta, is a
member of the family of S100 small molecular weight
(9–14 kDa) calcium-binding proteins, which are mainly
implicated in calcium sensing and signal transduction
[5]. Recent studies have shown that S100P is highly
expressed in many types of tumors [6-14] and influences
proliferation, invasion, survival, metastasis, angiogenesis
and resistance to chemotherapy drugs in a diverse group
of tumors [14-19]. In our previous work using dataLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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during the window of implantation, and a few other
microarray studies have also shown the same up-
regulation of S100P in LH + 7 or in the mid-secretory
phase with a 6- to 20-fold change [20-22].
It has long been observed that there are strikingly
similar biological processes between embryo implant-
ation and tumor development and that the biological
processes of proliferation, invasion, survival and angio-
genesis are of crucial significance to a receptive endo-
metrium and embryo implantation [23]. Thus, S100P
might play an important role in the establishment of
endometrial receptivity and embryo implantation.
The cyclical change of the endometrium is precisely
controlled by reproductive hormones from the
hypothalamus-pituitary-ovary axis. Studies of patients
with premature ovarian failure (POF) have shown that
E2 and P4 given sequentially can induce the establish-
ment of endometrial receptivity, which indicates that E2
and P4 are the dominant factors as well as the only ne-
cessary factors that control the establishment of endo-
metrial receptivity [24,25].
In a natural cycle, the granulosa cells of the developing
follicle produce E2 in response to gonadotropin stimula-
tion. Adequate E2 priming of the endometrium results in
endometrial proliferation and the induction of sufficient
P4 receptors to allow subsequent P4 stimulation for
endometrial receptivity. In response to P4, the endomet-
rium undergoes profound conformational and biochem-
ical changes, from proliferative to secretory, with a
concomitant induction of endometrial receptivity and
the opening of the window of implantation. Steroid hor-
mones act by regulating the expression of their down-
stream effectors [24].
Therefore, in the present study, we designed experi-
ments to verify the expression and location of S100P in
the human endometrium during the menstrual cycle,




The endometrial samples (n = 24) were obtained via a
pipelle catheter from fertile women, who provided
informed consent under a protocol approved by the
Committee of Fudan University Obstetrics and
Gynecology Hospital on the Use of Human Subjects in
Medical Research. Healthy volunteers or patients who
were pathologically confirmed to have benign cervical
lesions, aged 24 to 40, had regular cycles (27–33 d), and
had not taken steroid hormone medications within
3 months were enrolled in the study.
Eighteen of the samples were kept on ice and were im-
mediately transported to the laboratory. Some portionsof the samples were routinely embedded in optimal cut-
ting temperature (OCT) compound, and the frozen
blocks were subjected to hematoxylin and eosin staining
or immunofluorescence staining. The histological evalu-
ation was blindly conducted by two independent pathol-
ogists. The specimens were classified according to the
criteria of Noyes et al. [26] as proliferative phase (d8-14,
n = 6), early-secretory phase (d15-18, n = 4), mid-
secretory phase (d19-23, n = 5), and late-secretory phase
(d24-28, n = 3). The other specimens were snap-frozen
in liquid nitrogen for RNA and protein isolation.
Another six samples (mid- or late-proliferative phase)
were transported to the laboratory for primary cell
isolation.
Culture of primary cells
The six samples were mixed together for cell isolation.
Isolation of primary endometrial epithelial and stromal
cells (EECs and ESCs) was performed as described previ-
ously [27] with some modifications. The endometrial tis-
sues were minced (<0.1 mm3) before being digested via
incubation in Dulbecco’s minimum essential medium
(DMEM)/F-12 containing 0.25% type II collagenase
(Sigma, St. Louis, MO) at 37°C for 1 h. The dispersed
endometrial cells were separated into ESCs and EECs
by filtration through a nylon cell strainer with 40-um
pores. The filtered ESCs were centrifuged and plated
in DMEM/F-12 containing 10% fetal bovine serum
(Gibco, Australia) in 100-mm culture dishes. At the
first passage, they were placed on 6-well dishes at a
density of 5 × 105 cells per well. Those that had
reached confluence in 2 or 3 days were used for the
experiments.
Unfiltered glands were rinsed with more than 30 ml of
PBS before being back-flushed from the sieves. After
centrifuging, the EECs were planted on 35-mm culture
dishes at a density of 4 × 105 cells per well using the
same medium. Any ESCs remaining with EECs were fur-
ther separated by selective adherence to culture dishes
for 1 h. The cells that reached confluence in 2 or 3 days
were used for the experiments. The purity of both stro-
mal and epithelial cells was achieved by over 95%, as
determined by cellular staining with vimentin and cyto-
keratin (See Additional file 1, Figure S1).
Hormonal stimulation protocol
Cultured cells with a number of 1 × 105 were placed in
1 ml of medium and seeded into a 12-well plate, and
cultured cells with a number of 1 × 104 were placed in
200 μl of medium and seeded into a 96-well plate. Both
were subjected to 24-hour culture to achieve 50% con-
fluence in normal medium containing 10% FBS. The
half-confluent monolayers were maintained in serum-
free media for 48 h prior to hormonal stimulation. We
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at 10-8 mol/L, Progesterone (Sigma, USA) at 10-7 and E2
combined with P4 (10
-8 mol/L E2 with 10
-7 mol/L P4) for
48 h to test the response of S100P to reproductive hor-
mones. And then we chose P4 and stromal cells to
proceed the time and dose course experiments, treating
stromal cells with different concentrations of P4 (10
-7,
10-8 and 10-9 mol/L) for 48 h or P4 (10
-7 mol/L) for dif-
ferent periods of time (24, 48 and 72 h). The hormonally
treated cells that were seeded in 12-well plates were col-
lected for real-time reverse transcriptase-polymerase
chain reaction (real-time PCR) analysis, and those
seeded in 96-well plates were fixed for in-cell Western
analysis.RNA isolation and real-time PCR analysis
Total RNA was isolated using Trizol reagent (Invitrogen,
USA) and the cDNA generated using the RevertAidTM
First Strand cDNA Synthesis Kit (Fermentas, Canada)
according to the manufacturer’s protocol.
Quantitative PCR reactions were carried out with
SYBR Premix Ex Taq (Takara) and detected with an Ap-
plied Biosystem PRISM 7500HT system. The expression
of S100P was normalized to that of the beta-actin in all
samples. The primers were designed using the software






All experiments were performed in triplicate.Tissue immunofluorescence
Endometrial biopsies were embedded in optimum cut-
ting temperature compound (Tissue-Tech, Sakura Fine-
technical, Japan), snap-frozen, and cut into 5-μm thick
sections. After fixation in cold acetone for 30 min, the
sections were incubated with 5% bovine serum albumin
(BSA) for 30 minutes at room temperature. Afterwards,
they were incubated with mouse anti-human S100P
(R&D, diluted 1:50 in phosphate-buffered saline PBS) for
2 h at 37°C. After three 10-minute washes in PBS, the
sections were incubated with cy3-labeled goat anti-
mouse IgG (Invitrogen) at 1:500 for 1 h at room
temperature. The same washing procedures were per-
formed, and the nuclei were counterstained with
Hoechst33258 stain (Sigma) at 1 mg/ml. The cells were
then observed under a fluorescence microscope (Axio-
vert 200, Zeiss, Germany).Cellular immunofluorescence staining
To further observe the intracellular location of S100P in
the endometrial cells, immunofluorescence staining for
S100P was performed on cell climbing slices. Cell climb-
ing slices were placed on the bottom of 6-well dishes be-
fore seeding the first passage cells, which were
maintained in DMEM/F-12 containing 10% fetal bovine
serum. The slices were removed when the cells reached
50% confluence, and they were fixed in 3.7% formalde-
hyde for 20 min before being permeabilized and blocked
using PBS containing 0.1% Triton X-100 (Sigma) and 5%
BSA at 37°C for 45 min. The slices were incubated over-
night at 4°C with 1:50 mouse anti-human S100P mono-
clonal antibody (R&D Systems, Minneapolis, MN)
diluted in blocking buffer. They were washed three times
in PBS for 5 min and incubated with 1:500 cy3-labeled
goat anti-mouse IgG (Invitrogen) for 1 h at room
temperature. The same washing procedures were per-
formed again, and the nuclei were counterstained with
Hoechst33258 stain (Sigma) at 1 mg/ml. The cells were
observed under the same fluorescence microscope
(Axiovert 200, Zeiss, Germany).
In-cell western
In-cell Western, an immunocytochemical assay to quan-
tify proteins in fixed cells [29], was performed to evalu-
ate the protein level changes of S100P after hormonal
treatment. The cells were seeded in 96-well plates, and
treatments were performed as described above. The
medium was removed, the cells were fixed in 200 μl of
3.7% formaldehyde in PBS for 20 min, and they were
permeabilized and blocked using 200 μl PBS containing
0.1% Triton X-100 and 5% BSA at 37°C for 45 min.
Afterwards, they were incubated overnight at 4°C with
1:50 mouse anti-human S100P monoclonal antibody
(MAB2957, R&D Systems) and 1:200 rabbit anti-human
beta-actin antibody (1854–1, Epitomics, USA) diluted in
blocking buffer. They were washed three times with PBS
for 5 minutes, and the dishes were incubated with
1:1000 fluorescently labeled IRDye 800 anti-mouse and
IRDye 680 anti-rabbit secondary antibodies (KPL, USA)
for 1 h at room temperature, followed by the same
washing procedures. The negative controls were
obtained by omitting the primary antibodies. The inten-
sity of cellular staining was quantified by densitometry
using an Odyssey infrared imaging system (Li-Cor Bios-
ciences). The specificity of the primary antibodies has
been validated by Western blot prior to the experiments
(See Additional file 2, Figure S2).
Statistical analysis
The results are presented as the means ± SD of three to
six independent experiments. Statistical analyses were
performed using one-way ANOVA, followed by LSD
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considered statistically significant at P < 0.05. All experi-
ments were repeated at least three times.
Results
The mRNA expression of S100P in human endometrium
The results of real-time PCR analysis showed that the
mRNA expression of S100P was significantly up-regu-
lated, with a peak in the mid-secretory endometium
(MSE). The mRNA level in the MSE was 180 times as
high as that in the proliferative endometrium (PE), 90
times as high as that in the early-secretory endometium
(ESE) and over 70 times as high as that in the late-
secretory endometium (LSE) (P < 0.01) (Figure 1).
The protein expression and tissue location of S100P in
human endometrium
Immunofluorescence was performed to detect the pro-
tein expression and location of S100P in the endomet-
rium during the menstrual cycle. In comparison with the
results of real-time PCR, the S100P protein expression
presented the same moving pattern, where S100P signals
were nearly undetected in the PE, slightly elevated in the
ESE, dramatically enhanced in the MSE and sharply
weakened in the LSE. In the MSE, the enhanced S100P
signals were distributed in the glands and the stroma,
but the highest immunoreactivity was located in the
glands (Figure 2).
The cellular location of S100P in endometrial cells
The cellular immunofluorescence staining was con-
ducted to observe the intracellular distribution of S100P.Figure 1 Expression level of S100P mRNA. The mean fold
changes of S100P mRNA expression in human endometrium are
shown; the four groups (PE, ESE, MSE, and LSE) contained 6, 4, 5,
and 3 samples, respectively; the data was normalized to that of PE;
and beta-actin was used as the housekeeping gene. PE: proliferative
endometrium, ESE: early-secretory endometrium, MSE: mid-secretory
endometrium, LSE: late-secretory endometrium (** P < 0.01).In the cultured primary endometrial epithelial and stro-
mal cells, S100P was expressed in both the cytoplasm
and the nucleus, although the signal intensity showed no
significant difference between the cytoplasm and the nu-
cleus (Figure 3).
Regulation of S100P by reproductive hormones in human
endometrium
We first observed the hormonal effects on S100P after
48 h of stimulation with the highest physiological dose
(E2, 10
-8 mol/L and P4, 10
-7 mol/L). In the primary epi-
thelial and stromal cells, the expression of S100P was
found to be strongly stimulated by P4, and its expression
rose 4-fold in EEC and 20-fold in ESC at both the
mRNA and protein level (P < 0.001). E2 alone showed no
obvious effects, and E2 combined with P4 did not display
marked synergistic effects (Figure 4). Then, we further
studied the time and dose effect of P4 on S100P in pri-
mary stromal cells. The expression of S100P peaked after
stimulation for 48 h, and was maximized at 10-7 mol/L.
(Figure 5).
Discussion
In the present study, we determined the peak expression
of S100P during the implantation window in terms of
both the mRNA and protein levels, which was approxi-
mately 100 times high as those in the other phases of
endometrium during the menstrual cycle. On the one
hand, it suggests that S100P could be chosen as a unique
biomarker of receptive endometrium. Moreover, the
most prominent S100P signal in the MSE were located
in the glands, which was not in accordance with the ex-
pression pattern found by Tong et al. [30], who showed
that S100P is distributed in the nuclei and observed
more intense S100P immune staining in the stroma
compared to that in the glands. However, our results
were similar to those for the gastric mucosa reported by
Parkkila et al., who reported that the highest immunor-
eactivity was located in the surface epithelial cells and
glands [31], suggesting that S100P has the potential to
be secreted into the uterine cavity and detected in the
uterine fluid as a non-invasive biomarker of endometrial
receptivity. On the other hand, it suggests that S100P
could be functionally related to the establishment and
withdrawal of endometrial receptivity, the secretory ac-
tivity of the endometrium and the maintenance of the
inter-uterine environment. It has been reported that the
expression of S100P increased 37-fold in stromal cells
after their co-culture with trophoblast cells [32], which
proved that S100P might be involved in interactions at
the maternal-fetal interface.
Previous studies have shown that S100P can be loca-
lized in the cytoplasm and/or the nucleus of a wide
range of cells, and as a secretory protein, it can also be
Figure 2 Expression level and tissue distribution of S100P protein. Immunofluorescence staining of S100P in human endometrium at PE
(E, F and G), ESE (I, J and K), MSE (M, N and O), and LSE (Q, R and S) are shown; PBS substituted for the primary antibody was used as the
negative control (A, B and C); Hoechst was used for nuclei staining (blue) (B, F, J, N and R); S100P fluorescent images (red) (A, E, I, M and O),
merged images (C, G, K, O and S), and hematoxylin and eosin (HE) staining (D, H, L, P and T) are shown; higher magnification view of the
selected areas in MSE staining (M, N and O) are shown in the lower right corner; scale bars represent 100um.
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present study, we observed that S100P is expressed in
the nucleus as well as in the cytoplasm of endometrial
cells and that it largely accumulated in the cytoplasm of
EECs and ESCs. The cellular location of S100P has been
reported to correspond to its molecular functions as fol-
lows: the intracellular component of S100P could inter-
act with Ezrin, a multi-domain link protein of the
membrane-cytoskeleton, thus playing a role in cell dif-
ferentiation, adhesion, and migration [34]; S100P in the
cytoplasm could bind to CacyBP/SIP, a component of
the ubiquitin pathway, which is involved in thedegradation of the cell signaling molecule ß-catenin
[35]; the extracellular-soluble form of S100P could func-
tion as a ligand of the RAGE receptor to modulate cell
proliferation and survival via activation of MAP kinase
and NF-kappa B pathway [10]; and the component of
S100P in the nucleus might bind to S100PBP (S100P
binding protein), the exact role of which remains
unclear.
It has been shown that cell proliferation, adhesion and
motility are all vital to endometrial receptivity and
embryo implantation, in which ß-catenin [36], MAP kin-
ase [37] and the NF-kappa B pathway [38] play an
Figure 3 Cellular location of S100P protein. Immunofluorescence staining of S100P in EEC (primary endometrial epithelial cells) (A, B and C)
and ESC (primary endometrial stromal cells) (D, E and F); PBS substituted for the primary antibody was used as the negative control (G, H and I);
Hoechst was used for nuclei staining (blue) (B, E and H), S100P fluorescent images (red) (A, D and G), and merged images (C, F and I); the scale
bars represent 50 μm.
Figure 4 Hormonal regulation of S100P. The variations of S100P under hormonal stimulations in primary endometrial cells (A: EEC, B: ESC). The
upper column graph shows the mRNA changes of S100P detected by real-time PCR; the lower panel indicats the protein level variations of S100P
detected by in-cell Western. The data were normalized to that of PE and used beta-actin as the internal reference. E: estrogen, P: progesterone,
EP: estrogen combined with progesterone, blank: unstimulated.
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Figure 5 Time course and dose-dependent reactions of S100P
to hormonal stimulations in ESC. The time course and
dose-dependent reaction of S100P under the P4 stimulations tested
in ESC are shown: the upper column graph shows the mRNA
changes of S100P detected by real-time PCR; the lower panel
indicates the protein level variations of S100P detected by in-cell
Western. The data was normalized to that of unstimulated and
used beta-actin as the internal reference. P: progesterone, blank:
unstimulated.
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of cytoskeleton-membrane connections [39], has also been
shown to be involved. These findings suggest that S100P
might act as a key linker participating in the formation of
endometrial receptivity and embryo implantation.
Elucidating the regulation of S100P is an important
step towards understanding the biological significance of
and proposing strategies for targeted S100P modulation
[14]. Recent studies have shown that DNA methylation
[40], IL-6 [41], bone morphogenic protein [42], prosta-
glandin E (PGE)/EP4 [43], glucocorticoid [44], and non-
steroidal anti-inflammatory drugs [45] could regulate
S100P expression during tumor progression. Steroid
hormones were also reported to play a role in the ex-
pression of S100P, including the synthetic androgen
R1881, which regulates the expression of S100P in pros-
tate cancer [46], as well as P4 and six other types of clin-
ically relevant synthetic progestins, which up-regulate
S100P in progesterone receptor (PR)-positive cell lines
of breast cancer [47].
In the present study, we verified that P4 can up-
regulate the expression of S100P in primary endometrial
cells. The results of the time course experiments showed
a parabolic shape, with a peak at 48 h, after which a
sharp drop was observed. The dose-dependent experi-
ments showed that S100P expression increased withincreasing P4 concentrations within a certain range. This
response explained the special temporal expression of
S100P during the window of implantation resulting from
the influence of P4. The level of progesterone secretion
may have peaked at the mid-secretory phase in concert
with the peak value of S100P expression, and the expres-
sion of S100P may have declined significantly with the
time extension of progesterone at the late-secretory
phase, although the concentration of progesterone
decreased little.
Conclusions
For the first time, we systematically clarified the expres-
sion and hormonal regulation of S100P in endometrial
cells, and we found that its expression peaked during the
window of implantation and that progesterone could
function as effective regulators of S100P expression. The
results indicate that S100P participates in periodic
changes of the endometrium under the regulation of
progesterone, that it might perform an important func-
tion in regulating endometrial development during the
menstrual cycle and in developing conditions necessary
for embryo implantation, and that it might be used as a
unique biomarker of a receptive endometrium.
Additional files
Additional file 1: Figure S1. The purity staining of EECs and ESCs. Cell
immunocytochemical characterization of EECs and ESCs are shown.
Immunocytochemistry shows that EECs express cytokeratin 7 (C) but do
not express vimentin (E), and ESCs express vimentin (F) but do not
express cytokeratin 7 (D). PBS substituted for the primary antibody was
used as the negative control (A and B). Scale bar = 50 um.
Additional file 2: Figure S2. The specificity validation of the primary
antibodies. The mouse anti-human S100P monoclonal antibody (1:1000)
and rabbit anti-human beta-actin antibody (1:3000) were used as the
primary antibody in Western blot analysis. Total 40 μg protein of each
column was used. The upper panel shows the S100P signal detected
from negative (A and B) and positive (C and D) controls, and the lower
panel shows the equal of loading samples stained by beta-actin
antibody.
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